By MARIA CHENG, AP Medical Writer LONDON (AP) — Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19. The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir []
The post Health Experts Slam US Deal For Large Supply Of Virus Drug appeared first on Afro.
